In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria

被引：2

作者：

Funke, G

Troxler, R

机构：

[1] Gartner & Colleagues Labs, Dept Med Microbiol & Hyg, D-88212 Ravensburg, Germany

[2] Pfizer AG Suisse, CH-8052 Zurich, Switzerland

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2005年 / 24卷 / 11期

关键词：

D O I：

10.1007/s10096-005-0036-4

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：769 / 771

页数：3

共 50 条

[21] Activity of quinupristin/dalfopristin against Gram-positive bacteria: Clinical applications and therapeutic potential
Rubinstein, E
Bompart, F
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 : 139 - 143
[22] In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistantStreptococcus pneumoniae
R. R. Reinert
M. Kresken
V. Mechery
M. Lemperle
R. Lütticken
European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 (9): : 662 - 665
[23] In vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis carinii
Walzer, PD
Ashbaugh, A
Collins, M
Cushion, MT
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3234 - 3237
[24] Linezolid is active in vitro against quinupristin/dalfopristin resistant enterococci and staphylococci
Siddiqui, F
Peterson, LR
Noskin, GA
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1179 - 1179
[25] In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci
Auckenthaler, R
Courvalin, P
Féger, C
Roche, G
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (11) : 608 - 612
[26] IN VITRO ACTIVITIES OF QUINUPRISTIN/DALFOPRISTIN IN COMBINATION WITH VANCOMYCIN AND GATIFLOXACIN AGAINST STAPHYLOCOCCUS AUREUS AND ENTEROCOCCUS FAECIUM CLINICAL ISOLATES
Guelden, Erdinc
Ermertcan, Safak
MIKROBIYOLOJI BULTENI, 2009, 43 (01): : 53 - 60
[27] In vitro activity of RP 59500 (quinupristin dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium
Ristow, TA
Noskin, GA
Warren, JR
Peterson, LR
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (04): : 335 - 339
[28] In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid)
Ling, TKW
Fung, KSC
Cheng, AFB
CHEMOTHERAPY, 2001, 47 (04) : 243 - 249
[29] Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: A comparison with ciprofloxacin
HamiltonMiller, JMT
Shah, S
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 : 103 - 108
[30] In vitro activity of quinupristin/dalfopristin, RP59500, against gram-positive clinical isolates
Qadri, SMH
Ueno, Y
AbuMostafa, FM
Halim, M
CHEMOTHERAPY, 1997, 43 (02) : 94 - 99

← 1 2 3 4 5 →